Cargando…
Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes
INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) frequently coexists with type 2 diabetes mellitus (T2DM) and synergistically contributes to the development of atherosclerosis. Flow-mediated dilation (FMD) is a commonly used noninvasive test for assessing endothelial function. The main objecti...
Autores principales: | Montazeri, Zeinab, Hashemi-Madani, Nahid, Iraji, Hamed, Sohrabi, Masoudreza, Alaei-Shahmiri, Fariba, Emami, Zahra, Babaei, Mohammad Reza, Malek, Mojtaba, Khamseh, Mohammad E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518908/ https://www.ncbi.nlm.nih.gov/pubmed/37749528 http://dx.doi.org/10.1186/s12902-023-01460-w |
Ejemplares similares
-
Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Taheri, Hoda, et al.
Publicado: (2020) -
The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM)
por: Soltanieh, Samira, et al.
Publicado: (2023) -
Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial
por: Attaran, Fereshte, et al.
Publicado: (2023) -
International Scientific Collaboration on Pituitary Research: A Social Network Analysis
por: Hashemi-Madani, Nahid, et al.
Publicado: (2021) -
Typical chest CT features can determine the severity of COVID-19: A systematic review and meta-analysis of the observational studies
por: Hashemi-madani, Nahid, et al.
Publicado: (2021)